Stokes Capital Advisors
LLY icon

Stokes Capital Advisors’s Eli Lilly LLY Stock Holding History

Stokes Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.4M Buy
9,865
+86
+0.9% +$101K 2.51% 9
2026
Q2 		$11.7M Buy
9,779
+3,493
+56% +$3.57M 2.51% 8
2026
Q1 		$5.78M Buy
6,286
+5,488
+688% +$5.56M 1.3% 36
2025
Q4 		$858K Buy
+798
New +$763K 0.2% 57

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Stokes Capital Advisors's LLY Position: Q3 2026 in Review

Stokes Capital Advisors increased its Eli Lilly (LLY) stake by 0.88% in Q3 2026, buying an estimated $101K and bringing the position to 9,865 shares worth $11.4M. The position accounts for 2.51% of the portfolio, ranked #9.

Stokes Capital Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $11.7M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Stokes Capital Advisors held 9,865 shares of Eli Lilly worth $11.4M as of Q3 2026.
  • Stokes Capital Advisors bought 86 Eli Lilly shares in Q3 2026, an estimated $101K.
  • Eli Lilly made up 2.51% of Stokes Capital Advisors's portfolio in Q3 2026, its #9 holding.
  • Stokes Capital Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Stokes Capital Advisors's Eli Lilly position peaked at $11.7M in Q2 2026.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Stokes Capital Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.